Long-term survival benefit of ruxolitinib in a patient with relapsed refractory chronic active Epstein-Barr virus

被引:6
作者
Jin, Zhili [1 ]
Wang, Yini [1 ]
Wang, Jingshi [1 ]
Zhang, Jia [1 ]
Wu, Lin [1 ]
Wang, Zhao [1 ]
机构
[1] Capital Med Univ, Beijing Friendship Hosp, Dept Hematol, 95 Yong An Rd, Beijing 100050, Peoples R China
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
D O I
10.1007/s00277-019-03647-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2003 / 2004
页数:2
相关论文
共 3 条
  • [1] Chronic Active Epstein-Barr Virus Disease
    Kimura, Hiroshi
    Cohen, Jeffrey I.
    [J]. FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [2] Onozawa Erika, 2018, Oncotarget, V9, P31077, DOI 10.18632/oncotarget.25780
  • [3] Palmason Robert, 2015, BMC Hematol, V15, P10, DOI 10.1186/s12878-015-0029-1